Found: 20
Select item for more details and to access through your institution.
Introduction to the diagnosis and classification of monocytic-lineage leukemias by flow cytometry.
- Published in:
- Cytometry. Part B, 2017, v. 92, n. 3, p. 218, doi. 10.1002/cyto.b.21219
- By:
- Publication type:
- Article
Immunophenotype of normal vs. myeloma plasma cells: Toward antibody panel specifications for MRD detection in multiple myeloma.
- Published in:
- Cytometry. Part B, 2016, v. 90, n. 1, p. 61, doi. 10.1002/cyto.b.21265
- By:
- Publication type:
- Article
Utility of CD54, CD229, and CD319 for the identification of plasma cells in patients with clonal plasma cell diseases.
- Published in:
- Cytometry. Part B, 2016, v. 90, n. 1, p. 91, doi. 10.1002/cyto.b.21269
- By:
- Publication type:
- Article
Recommendations for the study of monoclonal gammopathies in the clinical laboratory. A consensus of the Spanish Society of Laboratory Medicine and the Spanish Society of Hematology and Hemotherapy. Part I: Update on laboratory tests for the study of monoclonal gammopathies
- Published in:
- Clinical Chemistry & Laboratory Medicine, 2023, v. 61, n. 12, p. 2115, doi. 10.1515/cclm-2023-0326
- By:
- Publication type:
- Article
Recommendations for the study of monoclonal gammopathies in the clinical laboratory. A consensus of the Spanish Society of Laboratory Medicine and the Spanish Society of Hematology and Hemotherapy. Part II: Methodological and clinical recommendations for the diagnosis and follow-up of monoclonal gammopathies
- Published in:
- Clinical Chemistry & Laboratory Medicine, 2023, v. 61, n. 12, p. 2131, doi. 10.1515/cclm-2023-0325
- By:
- Publication type:
- Article
Circulating Tumor Cells (CTCs) for Comprehensive and Multiregional Non-Invasive Genetic Characterization of Multiple Myeloma (MM).
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2019, v. 19, p. e351, doi. 10.1016/j.clml.2019.09.580
- By:
- Publication type:
- Article
Prognostic implications of MRD assessment in multiple myeloma patients: comparison of Next-Generation Sequencing and Next-Generation Flow.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2019, v. 19, p. e47, doi. 10.1016/j.clml.2019.09.071
- By:
- Publication type:
- Article
Immunophenotypic assessment of clonal plasma cells and B-cells in bone marrow and blood in the diagnostic classification of early stage monoclonal gammopathies: an iSTOPMM study.
- Published in:
- Blood Cancer Journal, 2023, v. 13, n. 1, p. 1, doi. 10.1038/s41408-023-00944-1
- By:
- Publication type:
- Article
Comparison of next-generation sequencing (NGS) and next-generation flow (NGF) for minimal residual disease (MRD) assessment in multiple myeloma.
- Published in:
- Blood Cancer Journal, 2020, v. 10, n. 10, p. 1, doi. 10.1038/s41408-020-00377-0
- By:
- Publication type:
- Article
The Proliferation Index of Specific Bone Marrow Cell Compartments from Myelodysplastic Syndromes Is Associated with the Diagnostic and Patient Outcome.
- Published in:
- PLoS ONE, 2012, v. 7, n. 8, p. 1, doi. 10.1371/journal.pone.0044321
- By:
- Publication type:
- Article
Flow cytometric minimal residual disease assessment in B‐cell precursor acute lymphoblastic leukaemia patients treated with CD19‐targeted therapies — a EuroFlow study.
- Published in:
- British Journal of Haematology, 2022, v. 197, n. 1, p. 76, doi. 10.1111/bjh.17992
- By:
- Publication type:
- Article
Interlaboratory Analytical Validation of a Next-Generation Sequencing Strategy for Clonotypic Assessment and Minimal Residual Disease Monitoring in Multiple Myeloma.
- Published in:
- Archives of Pathology & Laboratory Medicine, 2022, v. 146, n. 7, p. 862, doi. 10.5858/arpa.2021-0088-OA
- By:
- Publication type:
- Article
Quality assessment program for Euro Flow protocols: Summary results of four-year (2010-2013) quality assurance rounds.
- Published in:
- Cytometry. Part A, 2015, v. 87, n. 2, p. 145, doi. 10.1002/cyto.a.22581
- By:
- Publication type:
- Article
Lenalidomide Maintenance and Measurable Residual Disease in a Real-World Multiple Myeloma Transplanted Population Receiving Different Treatment Strategies Guided by Access to Novel Drugs in Brazil.
- Published in:
- Cancers, 2023, v. 15, n. 5, p. 1605, doi. 10.3390/cancers15051605
- By:
- Publication type:
- Article
Reference Values to Assess Hemodilution and Warn of Potential False-Negative Minimal Residual Disease Results in Myeloma.
- Published in:
- Cancers, 2021, v. 13, n. 19, p. 4924, doi. 10.3390/cancers13194924
- By:
- Publication type:
- Article
B-Cell Regeneration Profile and Minimal Residual Disease Status in Bone Marrow of Treated Multiple Myeloma Patients.
- Published in:
- Cancers, 2021, v. 13, n. 7, p. 1704, doi. 10.3390/cancers13071704
- By:
- Publication type:
- Article
Monocyte Subsets and Serum Inflammatory and Bone-Associated Markers in Monoclonal Gammopathy of Undetermined Significance and Multiple Myeloma.
- Published in:
- Cancers, 2021, v. 13, n. 6, p. 1454, doi. 10.3390/cancers13061454
- By:
- Publication type:
- Article
STAT3 and STAT5B Mutations in T/NK-Cell Chronic Lymphoproliferative Disorders of Large Granular Lymphocytes (LGL): Association with Disease Features.
- Published in:
- Cancers, 2020, v. 12, n. 12, p. 3508, doi. 10.3390/cancers12123508
- By:
- Publication type:
- Article
Detection of Circulating Tumor Plasma Cells in Monoclonal Gammopathies: Methods, Pathogenic Role, and Clinical Implications.
- Published in:
- Cancers, 2020, v. 12, n. 6, p. 1499, doi. 10.3390/cancers12061499
- By:
- Publication type:
- Article
Altered innate immune profile in blood of systemic mastocytosis patients.
- Published in:
- Clinical & Translational Allergy, 2022, v. 12, n. 6, p. 1, doi. 10.1002/clt2.12167
- By:
- Publication type:
- Article